Lupin, Schering Settle Clarinex Patent Dispute; Glenmark, Nycomed Clash Over Cutivate
This article was originally published in The Pink Sheet Daily
Executive Summary
Indian drug companies are increasingly settling patent disputes to cut litigation costs and secure revenue streams.